Quest Diagnostics As of November 25, 2022 ticker dps (an.) 2022 hike 2021 hike 2020 hike
DGX $2.64 6.5% 10.7% 5.7%
Business yield Hike yrs 5 yr CAGR freq. paid since
Diagnostic Information Services 1.8% 12 8.0% Quarter 2004

Quest Diagnostics Inc. (DGX) announced today that the Company's Board of Directors declared a cash dividend of $0.66 per common share payable on April 20, 2022, to stockholders of record at the close of business on April 6, 2022.

This 6.5 percent dividend hike in 2022 follows a dividend hike of 10.7 percent to $0.62 per share in 2021. This also marks the 12th consecutive year of annualized dividend increases by the clinical lab results database provider.

A new annualized dividend rate of $2.64 per share yields 1.9% at a stock price of $140.52. Quest Diagnostics will pay shareholders a total annual dividend of $323 million if we include this new hike just announced.

Quest Diagnostics Incorporated is a provider of diagnostic information services. Quest Diagnostics ows the world's largest database of clinical lab results and the company's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. DGX's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.

Dividend Calendar

Look at the complete list of upcoming events
Ex-date Ticker Yield YTD hike
Dec 05 ROST 1.1% 8.8%
Dec 05 CI 1.2% 0.0%
Dec 06 AVY 1.4% 0.0%
Dec 06 ODFL 0.4% 50.0%
Dec 06 BLK 2.6% 18.2%
Dec 06 AEE 2.7% 7.3%
Dec 06 AME 0.6% 10.0%
Dec 06 SLB 1.4% 40.0%
Dec 07 HAL 1.3% 166.7%
Dec 07 NEM 4.8% 0.0%